-
Mashup Score: 0
A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable differences in treatment patterns, discontinuation rates, persistence, and adherence among psoriasis patients treated with different biologics including tildrakizumab, risankizumab, guselkumab, and ustekinumab, with implications for clinical decision-making based on early versus late disease onset and prior biologic exposure.
Source: www.ajmc.comCategories: General Medicine NewsTweet
-
Mashup Score: 0AAD 2025 Insights: Treatment Patterns in Moderate to Severe Psoriasis Patients on Biologics - 13 day(s) ago
A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable differences in treatment patterns, discontinuation rates, persistence, and adherence among psoriasis patients treated with different biologics including tildrakizumab, risankizumab, guselkumab, and ustekinumab, with implications for clinical decision-making based on early versus late disease onset and prior biologic exposure.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
How do real-world treatment patterns differ across psoriasis biologics? #AAD2025 data from 31K+ patients reveals key insights on use, adherence, and disease onset impacts for tildrakizumab, Risankizumab, and more. Watch the episode here: https://t.co/XoduwgHxqK
-
-
Mashup Score: 0The Medical Sisterhood: Empower Hour at AAD 2025 - 2 month(s) ago
Latanya Benjamin, MD, and Lindsay Ackerman, MD, joins The Medical Sisterhood in a live recording at AAD 2025 to discuss advocacy, mentorship, and empowerment.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
🚨 Have you seen the live recording of The Medical Sisterhood podcast (The Empower Hour) filmed at #AAD2025? If not, check it out here... https://t.co/w25dNRypsU 3 leaders in dermatology discuss advocacy, embracing discomfort, and their own journeys. Enjoy! https://t.co/UDF1Zhs8AJ
-
-
Mashup Score: 0The Medical Sisterhood: Empower Hour at AAD 2025 - 2 month(s) ago
Latanya Benjamin, MD, and Lindsay Ackerman, MD, joins The Medical Sisterhood in a live recording at AAD 2025 to discuss advocacy, mentorship, and empowerment.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
🚨 Have you seen the live recording of The Medical Sisterhood podcast (The Empower Hour) filmed at #AAD2025? If not, check it out here... https://t.co/w25dNRypsU 3 leaders in dermatology discuss advocacy, embracing discomfort, and their own journeys. Enjoy! https://t.co/UDF1Zhs8AJ
-
-
Mashup Score: 0The Medical Sisterhood: Empower Hour at AAD 2025 - 2 month(s) ago
Latanya Benjamin, MD, and Lindsay Ackerman, MD, joins The Medical Sisterhood in a live recording at AAD 2025 to discuss advocacy, mentorship, and empowerment.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
🚨 Have you seen the live recording of The Medical Sisterhood podcast (The Empower Hour) filmed at #AAD2025? If not, check it out here... https://t.co/w25dNRypsU 3 leaders in dermatology discuss advocacy, embracing discomfort, and their own journeys. Enjoy! https://t.co/UDF1Zhs8AJ
-
-
Mashup Score: 2AAD 2025: Conference Recap - 2 month(s) ago
Catch up on all coverage from the 2025 American Academy of Dermatology Annual Meeting held in Orlando, Florida, March 7-11.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🔑✨👥 Catch up on all of Dermatology Times' coverage from the 2025 American Academy of Dermatology Annual Meeting held in Orlando, Florida, March 7-11. Read our full recap below! #AAD2025 🌴⬇️ https://t.co/TZ07squOau
-
-
Mashup Score: 1Closing Out AAD With Dermatology Times’ Editor in Chief - 2 month(s) ago
Christopher Bunick, MD, PhD, shares concluding remarks with colleagues at AAD 2025.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
💡👥 Our Editor in Chief, Christopher Bunick, MD, PhD, shares concluding remarks about #AAD2025 https://t.co/qati5PPQBh
-
-
Mashup Score: 0American Academy of Dermatology - 2 month(s) ago
Coverage of the American Academy of Dermatology’s annual meeting. Disclaimer: This content was developed independently and is not endorsed by the American Academy of Dermatology.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Our team is here at the @SkinOfColor (SOCS) Scientific Symposium Medical Student Breakfast! Medical students & SOCS members are here in what is shaping up to be an impactful meeting. Stay tuned! View our latest coverage here at #AAD2025 for more: https://t.co/zoIIVfGKr0 https://t.co/h0Z8yK1rxK
-
-
Mashup Score: 0
Combined analysis of data from a pair of post-registrational studies demonstrate the clinical profile and patient opinion on treatment with tirbanulin.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
From #AAD2025: Tirbanibulin Reduces Actinic Keratosis Lesions, Achieves High Patient Satisfaction https://t.co/wZqRRDckJh
-
-
Mashup Score: 0Advances in Treatment Resistant Port-Wine Birthmarks: Emerging Therapies and Future Directions - 2 month(s) ago
Expect exciting news in the treatment of port-wine birthmarks, Kristen Marie Kelly, MD, told AAD Annual Meeting attendees.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
Kristen Marie Kelly, MD, highlighted promising advancements in the treatment of vascular malformations, particularly port-wine birthmarks at #AAD2025. Although lasers have significantly improved patient outcomes, she said, some lesions remain resistant. https://t.co/KSJEZZDC5V
-
Insights from #AAD2025 explore cost, fatigue, and expectations. Join Paul Yamauchi, MD, PhD, for that and to learn more about the future of personalized biologic therapy based on comorbidities and biomarkers. Watch now: https://t.co/usgiYPRLQK